CoChat

Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice

Open access
Pelewicz, Katarzyna, Miśkiewicz, Piotr · 2021 · Diagnostics

The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index; 21 of the 88 sources its claims cite were checked for support.

Abstract

Glucocorticoids (GCs) are widely used due to their anti-inflammatory and immunosuppressive effects. As many as 1–3% of the population are currently on GC treatment. Prolonged therapy with GCs is associated with an increased risk of GC-induced adrenal insufficiency (AI). AI is a rare and often underdiagnosed clinical condition characterized by deficient GC production by the adrenal cortex. AI can be life-threatening; therefore, it is essential to know how to diagnose and treat this disorder. Not only oral but also inhalation, topical, nasal, intra-articular and intravenous administration of GCs may lead to adrenal suppression. Moreover, recent studies have proven that short-term (<4 weeks), as well as low-dose (<5 mg prednisone equivalent per day) GC treatment can also suppress the hypothalamic–pituitary–adrenal axis. Chronic therapy with GCs is the most common cause of AI. GC-induced AI remains challenging for clinicians in everyday patient care. Properly conducted GC withdrawal is crucial in preventing GC-induced AI; however, adrenal suppression may occur despite following recommended GC tapering regimens. A suspicion of GC-induced AI requires careful diagnostic workup and prompt introduction of a GC replacement treatment. The present review provides a summary of current knowledge on the management of GC-induced AI, including diagnostic methods, treatment schedules, and GC withdrawal regimens in adults.

Overview

CoChat Summary

TL;DR

Glucocorticoid-induced adrenal insufficiency (AI) is an underdiagnosed, potentially life-threatening complication of glucocorticoid therapy that can occur even with short-term or low-dose treatment and non-oral routes. This narrative review summarizes diagnostic approaches, glucocorticoid withdrawal regimens, HPA-axis recovery, and replacement treatment in adults.

Key findings

  • As many as 1–3% of the population are currently on glucocorticoid treatment, and AI after glucocorticoid withdrawal has been estimated at 48.7% for oral administration, 7.8% for inhalation, 4.7% for topical, and 4.2% for nasal administration.
  • Morning serum cortisol below 3 μg/dL rules in AI, while levels above 18 μg/dL practically rule out AI; dynamic testing is suggested when morning cortisol is between 3 and 15 μg/dL.
  • Normal age- and sex-adjusted DHEA-S predicts proper HPA-axis function with sensitivity 87.1%, specificity 86.7%, and positive predictive value 93.1%, though DHEA-S alone is a worse parameter than morning serum cortisol for GC-induced AI.
  • Recommended replacement for GC-induced AI is 15–20 mg/day of short-acting hydrocortisone; GC-induced AI may last up to 2–4 years after withdrawal, and recovery is unlikely after 4 years from diagnosis.

Methods

  • Narrative review of current knowledge on GC-induced AI in adults, including diagnostic methods, treatment schedules, and glucocorticoid withdrawal regimens.
  • No primary study design, sample, or statistical analysis is reported; the paper synthesizes prior literature, guidelines, and cited studies.
  • The review discusses baseline and dynamic adrenal testing, including SST, ITT, metyrapone, CRH, and glucagon stimulation tests, as well as MRI consideration and peri-operative stress dosing.

Limitations

  • The paper states that predictors of GC-induced AI have not been well identified, the right choice of stimulation test remains debated, and specific guidelines on the duration and regimen of glucocorticoid withdrawal are lacking.
  • The paper states that the utility of metyrapone, glucagon, and CRH stimulation tests in diagnosing GC-induced AI has not been sufficiently investigated, and HPA-axis suppression with IV glucocorticoids requires further investigation.
  • Evident from the text: this is a narrative review without a described systematic search strategy, quality appraisal, or meta-analysis, so recommendations depend on cited guidelines and selected literature.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.3390/diagnostics11040728

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Diagnostic algorithm for patients before and after glucocorticoid withdrawal. Diagnostic workup should never postpone the start of GC replacement treatment when suspecting adrenal crisis. Data from: Furst et al. Glucocorticoid withdrawal. UpToDate. Accessed on 29 March 2021; Fleseriu et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline (2016); Pofi et al. The short synacthen (corticotropin) test can be used to predict recovery of hypothalamo–pituitary–adrenal axis function (2018). Abbreviations: AI, adrenal insufficiency; GC, glucocorticoid; SST, short stimulation test with synthetic ACTH; 1 prednisone or equivalent; 2 as described in the GC withdrawal paragraph. Δ cortisol: 30-min cortisol minus basal cortisol.
Figure 1 Diagnostic algorithm for patients before and after glucocorticoid withdrawal. Diagnostic workup should never postpone the start of GC replacement treatment when suspecting adrenal crisis. Data from: Furst et al. Glucocorticoid withdrawal. UpToDate. Accessed on 29 March 2021; Fleseriu et al. Hormonal replacement in hypopituitarism in adults: an Endocrine Society Clinical Practice Guideline (2016); Pofi et al. The short synacthen (corticotropin) test can be used to predict recovery of hypothalamo–pituitary–adrenal axis function (2018). Abbreviations: AI, adrenal insufficiency; GC, glucocorticoid; SST, short stimulation test with synthetic ACTH; 1 prednisone or equivalent; 2 as described in the GC withdrawal paragraph. Δ cortisol: 30-min cortisol minus basal cortisol.CC BY · PubMed Central

Verification

Claims the paper makes

15 Valid · 0 Not valid · 37 Not checked · 2 Own results and interpretations

29 more claims · 8 with their cited sources checked

Create a free account to see all 54 claims and to verify the 67 references still open.

See all claims — free account
  • It may state two separate claims as one. 7
  • Probably not a substantial claim. 13

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Show all 71 references

Research works printed but not linked: 1

  1. Carroll T.B. Aron D.C. Findling J.W. Tyrrell J.B. Glucocorticoids and Adrenal Androgens Greenspan’s Basic & Clinical Endocrinology 10th ed. Gardner D.G. Shoback D. McGraw-Hill Education New York, NY, USA 2017 Available online: https://accessmedicine.mhmedical.com/content.aspx?bookid=2178§ionid=166249274 (accessed on 19 April 2021)

Cited by

See all 45

Metadata

Authors
Pelewicz, K., & Miśkiewicz, P.
Affiliations
Medical University of Warsaw (PL)
Corresponding author
Miśkiewicz, Piotr
Venue
Diagnostics
Publisher
MDPI AG
Published
2021-04-20
Volume
11
Issue
4
Pages
728
ISSN
2075-4418 (ISSN-L)
OpenAlex
W3154233620
Cited by
44
References
72
Citations by year
2026: 6 · 2025: 7 · 2024: 11 · 2023: 15 · 2022: 2 · 2021: 3
FWCI
1.19
Type
journal article
Language
en
Open access
Locations
  • Diagnostics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
Keywords
glucocorticoid-induced adrenal insufficiency, glucocorticoid withdrawal, glucocorticoid tapering, adrenal suppression, hypothalamic-pituitary-adrenal axis, glucocorticoid replacement therapy, low-dose glucocorticoid therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-07, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-07 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol and qwen3.8-omni-flash).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice. https://app.cochat.ai/papers/10.3390/diagnostics11040728
The paper
Pelewicz, K., & Miśkiewicz, P. (2021). Glucocorticoid withdrawal-an overview on when and how to diagnose adrenal insufficiency in clinical practice. Diagnostics. https://doi.org/10.3390/diagnostics11040728

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.